ACIP Live Meeting Archive - June 2013

Videos: June 19, 2013 (Day 1)

Welcome & Introductions [40:10 minutes]
- Opening Remarks
  Dr. J Temte
  Dr. L Pickering
Japanese Encephalitis [97:00 minutes]
- Introduction
  Dr. J Bocchini
- Safety and immunogenicity of JE-VC in children
  Dr. K Dubischar-Kastner
- GRADE evidence for JE-VC in children, Recommendations for use
  Dr. M Fischer
General Recommendations on Immunization [33:38 minutes]
- Overview
  Dr. J Duchin
- Preventing and managing adverse reactions
  Dr. A Kroger
Pertussis Vaccines [140:44 minutes]
- Introduction
  Dr. M Sawyer
- Pertussis in the United States and Tdap vaccine effectiveness
  Dr. A Acosta
- Tdap revaccination: safety and immunogenicity
  Dr. J Liang
- Decision and cost effectiveness analysis: a second dose of Tdap
  Dr. M. Messonnier, Dr. H Kamiya
- Work group conclusions on a second dose of Tdap
  Dr. J Liang
- Maternal Tdap and cocooning: experiences from Australia and the United Kingdom
  Dr. P McIntyre, Dr. D Salisbury
Human Papillomavirus (HPV) Vaccines [85:12 minutes]
- Introduction
  Dr. J Bocchini
- Merck pregnancy registry for quadrivalent HPV vaccine
  Dr. F Lievano
- Plans for updated ACIP statement
  Dr. E Dunne
- HPV vaccine program and impact monitoring
  Dr. L Markowitz

Rotavirus Vaccines: Update on Intussusception [142:24 minutes]
- Introduction: intussusception following RV5 and RV1
  Dr. M Vázquez
- VSD
  Mr. E Weintraub
- VAERS
  Ms. P Haber
- PRISM
  Dr. K Yih
- Australian data
  Dr. P McIntyre
- Summary and review of risk: benefit in the United States
  Dr. M Cortese
Role of Retail Pharmacies in Vaccine Delivery [59:22 minutes]
- The role of retail pharmacies/pharmacists in vaccine delivery in the United States
  Mr. M Rothholz
Herpes Zoster Vaccine [03:29 minutes]
- Update on Herpes Zoster Work Group activities
  Dr. J Duchin
Influenza [131:15 minutes]
- Introduction
  Dr. W Keitel
- Epidemiology/surveillance update
  Dr. L Finelli
- H7N9 update
  Dr. D Jernigan
- Preliminary data on 2012-2013 vaccine effectiveness
  Dr. M Thompson
- Vaccine safety update
  Dr. T Shimabukuro
- FluLaval Quadrivalent: GSK’s inactivated quadrivalent seasonal influenza vaccine manufactured in Quebec
  Dr. V Jain
- 2013-2013 recommendations
  Dr. L Grohskopf